Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 38

1.

Refining the Enrolment Process in Emergency Medicine Research.

Sahan KM, Channon KM, Choudhury RP, Kharbanda RK, Lee R, Sheehan M.

Eur J Cardiovasc Med. 2016 Apr;4(1):506-510.

2.

Data monitoring committees for pragmatic clinical trials.

Ellenberg SS, Culbertson R, Gillen DL, Goodman S, Schrandt S, Zirkle M.

Clin Trials. 2015 Oct;12(5):530-6. doi: 10.1177/1740774515597697. Epub 2015 Sep 15.

PMID:
26374679
3.

Why so little progress in therapeutic thrombolysis? The current state of the art and prospects for improvement.

Gurewich V.

J Thromb Thrombolysis. 2015 Nov;40(4):480-7. doi: 10.1007/s11239-015-1217-3. Review. No abstract available.

4.

Fibrinolytic Therapy in CCU Instead of Emergency Ward: How It Affects Door to Needle Time?

Zeraati F, Homayounfar S, Esna-Ashari F, Khalili M.

Int J Prev Med. 2014 Mar;5(3):308-12.

5.

Risks and Benefits of Thrombolytic, Antiplatelet, and Anticoagulant Therapies for ST Segment Elevation Myocardial Infarction: Systematic Review.

Nascimento BR, de Sousa MR, Demarqui FN, Ribeiro AL.

ISRN Cardiol. 2014 Feb 6;2014:416253. doi: 10.1155/2014/416253. eCollection 2014. Review.

6.

Role of thrombolysis in reperfusion therapy for management of AMI: Indian scenario.

Dalal J, Sahoo PK, Singh RK, Dhall A, Kapoor R, Krishnamurthy A, Shetty SR, Trivedi S, Kahali D, Shah B, Chockalingam K, Abdullakutty J, Shetty PK, Chopra A, Ray R, Desai D, Pachiyappan, Ratnaparkhi G, Sharma M, Sambasivam KA.

Indian Heart J. 2013 Sep-Oct;65(5):566-85. doi: 10.1016/j.ihj.2013.08.032. Epub 2013 Sep 23. Review. No abstract available.

7.

Medication, reperfusion therapy and survival in a community-based setting of hospitalised myocardial infarction.

O'Brien EC, Rose KM, Suchindran CM, Stürmer T, Chang PP, Chambless L, Guild CS, Rosamond WD.

Heart. 2013 Jun;99(11):767-73. doi: 10.1136/heartjnl-2012-303244. Epub 2013 Mar 2.

8.

Primary Angioplasty for the Treatment of Acute ST-Segment Elevated Myocardial Infarction: An Evidence-Based Analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2004;4(10):1-65. Epub 2004 Aug 1.

9.

Myocardial infarction in the elderly.

Carro A, Kaski JC.

Aging Dis. 2011 Apr;2(2):116-37. Epub 2010 Dec 23.

10.

The use of anticoagulation in pediatric cardiac disease.

Boris JR, Harris MA.

Images Paediatr Cardiol. 2003 Jul;5(3):1-35.

11.

Antithrombotic medication for cardioembolic stroke prevention.

Font MÀ, Krupinski J, Arboix A.

Stroke Res Treat. 2011;2011:607852. doi: 10.4061/2011/607852. Epub 2011 Jun 22.

12.

Intravenous thrombolytics for ischemic stroke.

Barreto AD.

Neurotherapeutics. 2011 Jul;8(3):388-99. doi: 10.1007/s13311-011-0049-x. Review.

13.
14.

Myocardial infarction (ST-elevation).

Wakai AP.

BMJ Clin Evid. 2011 Jan 7;2011. pii: 0202. Review.

15.

Warfarin and fibrinolysis--a challenging combination: an observational cohort study.

Saarinen S, Puolakka J, Boyd J, Väyrynen T, Luurila H, Kuisma M.

Scand J Trauma Resusc Emerg Med. 2011 Apr 5;19:21. doi: 10.1186/1757-7241-19-21.

16.

Differentiating pharmacologic agents used in catheter-directed thrombolysis.

Swischuk JL, Smouse HB.

Semin Intervent Radiol. 2005 Jun;22(2):121-9. doi: 10.1055/s-2005-871867.

17.

Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium.

Leon MB, Piazza N, Nikolsky E, Blackstone EH, Cutlip DE, Kappetein AP, Krucoff MW, Mack M, Mehran R, Miller C, Morel MA, Petersen J, Popma JJ, Takkenberg JJ, Vahanian A, van Es GA, Vranckx P, Webb JG, Windecker S, Serruys PW.

Eur Heart J. 2011 Jan;32(2):205-17. doi: 10.1093/eurheartj/ehq406. Epub 2011 Jan 6.

18.

A review of cardiogenic shock in acute myocardial infarction.

Khalid L, Dhakam SH.

Curr Cardiol Rev. 2008 Feb;4(1):34-40. doi: 10.2174/157340308783565456.

19.

Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease.

Elliott P, Chambers JC, Zhang W, Clarke R, Hopewell JC, Peden JF, Erdmann J, Braund P, Engert JC, Bennett D, Coin L, Ashby D, Tzoulaki I, Brown IJ, Mt-Isa S, McCarthy MI, Peltonen L, Freimer NB, Farrall M, Ruokonen A, Hamsten A, Lim N, Froguel P, Waterworth DM, Vollenweider P, Waeber G, Jarvelin MR, Mooser V, Scott J, Hall AS, Schunkert H, Anand SS, Collins R, Samani NJ, Watkins H, Kooner JS.

JAMA. 2009 Jul 1;302(1):37-48. doi: 10.1001/jama.2009.954.

20.

The joint effects of apolipoprotein B, apolipoprotein A1, LDL cholesterol, and HDL cholesterol on risk: 3510 cases of acute myocardial infarction and 9805 controls.

Parish S, Peto R, Palmer A, Clarke R, Lewington S, Offer A, Whitlock G, Clark S, Youngman L, Sleight P, Collins R; International Studies of Infarct Survival Collaborators.

Eur Heart J. 2009 Sep;30(17):2137-46. doi: 10.1093/eurheartj/ehp221. Epub 2009 Jun 11.

Items per page

Supplemental Content

Write to the Help Desk